Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anxiolytic effects of single-dose quetiapine XR in simple phobia
2008-001371-30Phase 2Completed
- Sponsor
- Universitätsklinikum Münster
- Start
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in specific phobia comparing quetiapine XR with placebo (2 arms). Primary endpoints: Amygdala activation during phobic exposure and Clinical anxiety and panic symptoms during exposure. Started Dec 2008; status: completed.
02
Drugs
quetiapine
03
Conditions
specific phobia
Beyond the preview
Go deeper on 2008-001371-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001371-30.